Astrana Health (ASTH) Projected to Announce Earnings on Thursday

Astrana Health (NASDAQ:ASTH) is projected to announce its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect Astrana Health to announce earnings of $0.3362 per share and revenue of $985.6850 million for the quarter. Parties may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 5:30 PM ET.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.45. The firm had revenue of $965.10 million during the quarter, compared to analysts’ expectations of $949.21 million. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.Astrana Health’s revenue was up 55.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.42 earnings per share. On average, analysts expect Astrana Health to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Astrana Health Stock Down 0.6%

ASTH opened at $35.70 on Wednesday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.35 and a current ratio of 1.35. The company has a market cap of $1.99 billion, a price-to-earnings ratio of 58.52 and a beta of 0.87. Astrana Health has a one year low of $18.08 and a one year high of $51.60. The business’s fifty day moving average is $41.54 and its two-hundred day moving average is $32.33.

Wall Street Analysts Forecast Growth

ASTH has been the subject of several research reports. Truist Financial lifted their price target on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a research note on Friday, May 8th. Barclays upgraded shares of Astrana Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $37.00 to $50.00 in a report on Tuesday, May 26th. BTIG Research lifted their target price on shares of Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, TD Cowen upped their price target on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, Astrana Health has a consensus rating of “Moderate Buy” and a consensus target price of $47.86.

Institutional Trading of Astrana Health

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada raised its stake in Astrana Health by 6.5% in the 1st quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after purchasing an additional 17,028 shares during the last quarter. AQR Capital Management LLC purchased a new stake in shares of Astrana Health during the first quarter worth about $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Astrana Health by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after buying an additional 1,263 shares in the last quarter. Jones Financial Companies Lllp raised its position in shares of Astrana Health by 4,365.2% in the first quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after buying an additional 10,913 shares during the last quarter. Finally, Intech Investment Management LLC raised its position in shares of Astrana Health by 5.8% in the first quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after buying an additional 2,462 shares during the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.